POSSE Project: A Community-Level Intervention for Black YMSM

Status Completed

Clinical Trial Summary

Black young men who have sex with men (BYMSM) are at high risk for contracting and transmitting HIV, and represent a priority population for developing effective interventions. Within the House Ball community (HBC), a clandestine subculture of the Black gay community, HIV is highly stigmatized. This stigma, coupled with high HIV prevalence rates and elevated levels of undiagnosed/untreated HIV infection, places BYMSM in HBCs at incredible risk for HIV infection. Community-level interventions that target social norms, behavior, and stigma in the HBC are sorely needed in order to make a broader impact among BYMSM. Building on prior work in the community, this study proposes to launch an innovative Effectiveness-Implementation Hybrid Type 2 trial to examine the effectiveness and implementation of a community-level HIV prevention intervention (called POSSE) based on popular opinion leader (POL) models across two cities with similar HBCs, Chicago and Philadelphia. The proposed study has two specific aims: 1) To determine the effectiveness of a POL intervention, POSSE, to decrease sexual risk behavior (UAI), STIs and HIV stigma among BYMSM in the HBC; and 2) To evaluate the processes, strategies, barriers and facilitators for the implementation of POSSE delivered across two distinct metropolitan areas with high HIV prevalence among BYMSM and similar House Ball Communities. To examine these aims, the investigators will first use social network strategies to identify, screen, and recruit POLs (n=75) from the Philadelphia HBC. The investigators will then gather baseline behavioral and biological (HIV/STI testing) data in both Chicago and Philadelphia (n=100 BYMSM per city) and train the Philadelphia POLs to implement the POSSE intervention. The investigators will conduct an implementation-focused process evaluation to assess fidelity to the POSSE intervention; number, content, spread, and acceptability of risk reduction messages; age appropriateness of the messages; acceptability of the overall intervention; and barriers/facilitators to implementation. Next, the investigators will complete follow-up assessments every 6 months post- intervention in both cities (n=100 BYMSM per city at each assessment point). The investigators will also assess behavior change in those delivering the intervention (POLs) at each assessment point. The investigators will conduct implementation-focused qualitative interviews with POLs (n=15) and community participants (n=30) from Philadelphia. Last, the investigators will implement POSSE in Chicago by repeating the steps outlined above, continuing assessments in both cities, and conducting qualitative interviews in Chicago.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Acquired Immunodeficiency Syndrome
HIV Infections
HIV/AIDS and Infections

Clinical Trial Details

NCT number	NCT03198663
Study type	Interventional
Source	Cook County Health
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2016
Completion date	April 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03063385` - Puerto Rico Cuidalos Parent-adolescent Program	N/A
Active, not recruiting	`NCT04283929` - Evaluation of Clinical Impacts and Costs of eHealth in Rwanda	N/A
Withdrawn	`NCT03938077` - A Community-University Approach to Preventing HIV	N/A
Completed	`NCT02316444` - Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda	Phase 4
Recruiting	`NCT04319367` - A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).	Phase 2
Completed	`NCT03368456` - Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention	N/A
Recruiting	`NCT04135443` - Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men	N/A
Completed	`NCT03404297` - Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya	N/A
Completed	`NCT03445351` - Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS	N/A
Completed	`NCT03252483` - Integrating HIV and Hepatitis C Screening in an Urban Emergency Department	N/A
Completed	`NCT02712801` - Antiretroviral Regime for Viral Eradication in Newborns	Phase 4
Completed	`NCT02406482` - Evaluating a Microfinance Intervention for Vulnerable Women in Kazakhstan	N/A
Recruiting	`NCT04788784` - Patient-Reported Outcomes HIV BItherapy
Recruiting	`NCT05300035` - Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.